BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36624655)

  • 1. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
    Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
    Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.
    Ibrahim F; Al Sabbagh A; Amer A; Soliman DS; Al Sabah H
    Am J Case Rep; 2020 Mar; 21():e921131. PubMed ID: 32150530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
    Yoshino T; Tanaka T; Sato Y
    J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
    Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
    Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features.
    Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
    Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
    Gautam A; Sreedharanunni S; Sachdeva MUS; Rana S; Kashyap D; Bose P; Bal A; Prakash G; Malhotra P; Das R; Varma N
    Int J Lab Hematol; 2021 Oct; 43(5):1123-1131. PubMed ID: 33455071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal panel of immunohistochemistry for the diagnosis of B-cell non-Hodgkin lymphoma using bone marrow biopsy: a tertiary care center study.
    Marwah N; Satiza M; Dalal N; Atri S; Gupta M; Singh S; Sen R
    Blood Res; 2021 Mar; 56(1):26-30. PubMed ID: 33504685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
    Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
    J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
    [No Abstract]   [Full Text] [Related]  

  • 14. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
    Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype.
    Aruga Y; Ikeda C; Matsushita H; Makita S; Fukuhara S; Munakata W; Izutsu K; Matsui H
    Sci Rep; 2024 Jun; 14(1):13452. PubMed ID: 38862612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
    Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
    Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
    Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
    Markowitz JT; Mazerolle F; Lovell T; Hess LM; Abada PB; Regnault A; Payakachat N
    J Patient Rep Outcomes; 2024 Jan; 8(1):8. PubMed ID: 38252198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
    Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.